Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14433714 | 1.00 | POLB (0.75) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL13589979 | 1.00 | POLB (0.75) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL14493662 | 1.00 | POLB (0.75) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL29838840 | 1.00 | POLB (0.75) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL5811871 | 0.90 | POLB (0.69) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL14341836 | 0.90 | POLB (0.64) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL6865696 | 0.90 | POLB (0.68) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL26217996 | 0.89 | POLB (0.62) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL1788313 | 0.88 | POLB (0.66) | POLBGAAALDH1A1TSHRLMNA | |
| SCHEMBL11577077 | 0.87 | POLB (0.60) | POLBGAAALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116059969-B | Copper-based metal organic framework material and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-116059969-A | Copper-based metal organic framework material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-108546224-B | Process for the manufacture of nitriles and their corresponding amines | 中国石化扬子石油化工有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-111825366-A | Concrete additive and preparation method thereof | 韩昌龙 | 2020-10-27 | — | — | CN | claimed |
| US-9587147-B2 | Pressure-sensitive adhesive compositions, polarizers and liquid crystal displays comprising the same | LG CHEM, LTD. (KR) | 2017-03-07 | — | — | US | claimed |
| US-20160246193-A1 | TONER AND METHOD FOR PRODUCING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2016-08-25 | — | — | US | claimed |
| US-20110032455-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS, POLARIZERS AND LIQUID CRYSTAL DISPLAYS COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2011-02-10 | — | — | US | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7670748-B2 | Cyclic compound, photoresist composition and method of forming a photoresist pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-03-02 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-20070141511-A1 | Cyclic compound, photoresist composition and method of forming a photoresist pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-06-21 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| WO-1999043356-A1 | ANTIBIOTIC-LIGAND CONJUGATES AND METHODS OF USE THEREOF | HSC RESEARCH DEVELOPMENT LIMITED PARTNERSHIP (CA) | 1999-09-02 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | POLB 1788/4885GAA 1358/4885ALDH1A1 1569/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | POLB 1132/4885GAA 958/4885ALDH1A1 1723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.